MIP Gruppe

The company

MIP Grruppe is an international manufacturer and distributor of generic pharmaceuticals with a focus on anti-infectives. In addition to antibiotics, MIP offers over-the-counter medicines and medical devices. Most of the products are manufactured at the company’s two production sites in Saarland, Germany. MIP owns marketing authorizations for approx. 400 pharmaceutical products and generates revenues of more than € 40 million with approx. 250 employees. The group is active in 19 countries.

In cooperation with the management team and supported by industry experts, capiton plans to leverage the company’s substantial local production capacity and international footprint to further strengthen MIP´s leading position in target niche markets.

The transaction

capiton acquired MIP Gruppe from the founding family together with the management team as well as senior industry experts. Financing of the transaction is provided by capiton’s current investment vehicle, capiton VI. Additional funds have been reserved to finance both organic and inorganic growth initiatives in Germany and abroad.

The transaction remains subject to approval from competition authorities. Sellers and buyers have agreed not to disclose the financial terms of the transaction.

capiton was advised by Hampton Pharma and Fidelio Healthcare Partners (Commercial), PwC (Financial), EY (Tax), BMH (Legal), Straeter Rechtsanwaelte (Pharma law), Dr. Regenold GmbH (Regulatory and technical due diligence), Willis Tower Watson (Insurance), AvS (Management audit) and Tauw (ESG & EDD).

Pressemitteilungen

capiton portfolio company Wundex is pleased to announce the acquisition of ELLIPSA, a wound care specialist with headquarters in Regensburg (Bavaria) and a second center of operations in Munich. In addition to the provision of wound care services and the wholesale supply of medical products, ELLIPSA has developed a proprietary digital education and training platform […]

capiton portfolio company Cedes is proud to announce the acquisition of the Vitector portfolio from Fraba, securing a leading position in the industrial door sensor market. As a global leader in elevator sensors, Cedes successfully applied its technology expertise and power of innovation to gain a foothold in the industrial door market, providing ultra-reliable safeguarding […]

Asyril SA, headquartered in Villaz-St-Pierre in Switzerland with subsidiaries in the US and Japan, is a market and technology leader in the flexible part feeder market. Its products are being used globally in assembly lines, facilitating process automation for a variety of industries.   Asyril’s product portfolio covers flexible feeding systems based on a patented […]

AlphaPet Ventures has started to implement its international expansion strategy with the acquisition of Arden Grange, a leading UK brand in the premium dog food segment. Family-run Arden Grange pioneered the category of species-appropriate dog food in the UK more than 25 years ago. Customers appreciate especially the high quality of the products, which aim […]

We are delighted to announce the successful acquisition of Stuga Machinery by our portfolio company Stürtz Group.   Stuga Machinery Limited, a market leading manufacturer of PVC sawing and machining centres to the UK and Ireland windows and doors industry, has been acquired by Stürtz Group. All of Stuga’s Directors and staff are continuing with […]

We are delighted to announce that our portfolio company EVP Group is combining forces with Vitafy Brands. Founded in Munich in 2014, Vitafy Brands has grown to be a leading consumer health D2C online platform for its own brands focusing on the development and offering of functional Consumer Health OTC products for health focused customers. […]

capiton acquires a majority stake in the Betonbau Group alongside its experienced management team, Mr. Volker Ernst and Mr. Thomas Sachers, from the SCHWENK Group in a carve-out transaction. Betonbau Group, headquartered in Waghäusel, Germany, was established in 1963. The name “Betonbau” goes back to its foundations when the company focused on the production of […]

capiton successfully closes fund VI at €504 million Largest fund in the company’s history Approximately €260 million, including co-investment, already deployed in seven portfolio companies Fund to continue successful deployment in capiton’s focus sectors Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption   Berlin, 24 November 2021 – capiton AG (“capiton”), a leading owner-managed private […]

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service […]